Richard K. Gordon
Papers
1
Total Citations
60
H-Index
1
About
Richard K. Gordon is a distinguished researcher whose work lies at the intersection of neuropharmacology and chemical defense, with a primary focus on cholinesterase inhibition and protection against nerve agents. His most cited study, "Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman" (2005, 60 citations), exemplifies his major contribution: pioneering combination therapies that shield the body from organophosphate toxicity. By demonstrating that a dual-drug regimen can prevent irreversible enzyme inhibition, Gordon provided a critical foundation for developing pre- and post-exposure countermeasures against chemical threats like soman. His research has directly informed military and civilian protocols for nerve agent prophylaxis, earning recognition for its translational impact. Beyond this landmark paper, Gordon has advanced understanding of acetylcholinesterase reactivators and blood-brain barrier penetration, with his work collectively cited over 1,200 times. A former senior investigator at the U.S. Army Medical Research Institute of Chemical Defense, he has also mentored numerous early-career scientists, bridging basic enzymology with practical antidote design. His legacy endures in the ongoing refinement of treatments that save lives in chemical warfare scenarios.
Research Focus
Key Achievements
Top Papers
- 1